Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Neutrophil function and glutathione-peroxidase (GSH-px) activity in healthy individuals after treatment with N-acetyl-L-cysteine.

Urban T, Akerlund B, Jarstrand C, Lindeke B.

Biomed Pharmacother. 1997;51(9):388-90.

PMID:
9452788
2.

Effect of N-acetylcysteine(NAC) treatment on HIV-1 infection: a double-blind placebo-controlled trial.

Akerlund B, Jarstrand C, Lindeke B, Sönnerborg A, Akerblad AC, Rasool O.

Eur J Clin Pharmacol. 1996;50(6):457-61.

PMID:
8858271
5.

Cellular effects of some metabolic oxidation products pertinent to 4-ethoxyaniline.

Lindqvist T, Moldéus P, Lindeke B.

Pharmacol Toxicol. 1991 Aug;69(2):117-21.

PMID:
1775431
7.

Absorption of a pharmacological dose of vitamin D3 from two different lipid vehicles in man: comparison of peanut oil and a medium chain triglyceride.

Holmberg I, Aksnes L, Berlin T, Lindbäck B, Zemgals J, Lindeke B.

Biopharm Drug Dispos. 1990 Dec;11(9):807-15.

PMID:
2176898
8.

The protective effect of sulfite on menadione- and diquat-induced cytotoxicity in isolated rat hepatocytes.

Sun YP, Cotgreave IA, Lindeke B, Moldéus P.

Pharmacol Toxicol. 1990 May;66(5):393-8.

PMID:
2371247
10.

The metabolism of sulfite in liver. Stimulation of sulfate conjugation and effects on paracetamol and allyl alcohol toxicity.

Sun YP, Cotgreave I, Lindeke B, Moldéus P.

Biochem Pharmacol. 1989 Dec 1;38(23):4299-305.

PMID:
2597201
11.

Biotransformation of terodiline. V. Stereoselectivity in hydroxylation by human liver microsomes.

Norén B, Strömberg S, Ericsson O, Lindeke B.

Chem Biol Interact. 1989;71(4):325-37.

PMID:
2582539
12.

Single-dose pharmacokinetics of terodiline, including a stable isotope technique for improvement of statistical evaluations.

Hallén B, Guilbaud O, Strömberg S, Lindeke B.

Biopharm Drug Dispos. 1988 May-Jun;9(3):229-50.

PMID:
3395665
13.

Biotransformation of terodiline. IV. Identification of unconjugated and conjugated metabolites in dog and human urine.

Norén B, Strömberg S, Ericsson O, Lindeke B.

Acta Pharm Suec. 1988;25(6):281-92. No abstract available.

PMID:
3245454
15.

Biotransformation of terodiline. III. Opposed stereoselectivity in the benzylic and aromatic hydroxylations in rat liver microsomes.

Lindeke B, Ericsson O, Jönsson A, Noren B, Strömberg S, Vangbo B.

Xenobiotica. 1987 Nov;17(11):1269-78.

PMID:
3433799
16.
17.

Cellular effects of N(4-ethoxyphenyl)p-benzoquinone imine, a p-phenetidine metabolite formed during peroxidase reactions.

Larsson R, Lindqvist T, Lindeke B, Moldéus P.

Chem Biol Interact. 1986 Dec;60(3):317-30.

PMID:
3791494
18.

Peroxidative N-oxidation and N-dealkylation reactions of pargyline.

Weli AM, Lindeke B.

Xenobiotica. 1986 Mar;16(3):281-8.

PMID:
3705622
19.

The metabolic fate of pargyline in rat liver microsomes.

Weli AM, Lindeke B.

Biochem Pharmacol. 1985 Jun 1;34(11):1993-8.

PMID:
3924052
20.

The oxidation of p-phenetidine by horseradish peroxidase and prostaglandin synthase and the fate of glutathione during such oxidations.

Ross D, Larsson R, Andersson B, Nilsson U, Lindquist T, Lindeke B, Moldéus P.

Biochem Pharmacol. 1985 Feb 1;34(3):343-51.

PMID:
2982385
21.

N-dealkylation and N-oxidation of two alpha-methyl-substituted pargyline analogues in rat liver microsomes.

Weli AM, Höök BB, Lindeke B.

Acta Pharm Suec. 1985;22(5):249-64. No abstract available.

PMID:
4090997
22.

Biotransformation of terodiline. II. Disposition in the male rat. Identification of metabolites in rat urine and rat liver microsomes by mass spectrometry.

Norén B, Strömberg S, Ericsson O, Vangbo B, Grälls M, Widlund L, Lindeke B.

Acta Pharm Suec. 1985;22(3):131-46. No abstract available.

PMID:
4036638
23.

Reactive products formed by peroxidase catalyzed oxidation of p-phenetidine.

Larsson R, Ross D, Nordenskjöld M, Lindeke B, Olsson LI, Moldéus P.

Chem Biol Interact. 1984 Nov;52(1):1-14.

PMID:
6499076
25.

Cytochrome P-455 nm complex formation in the metabolism of phenylalkylamines. VII. Enzyme interactions with synthetic 2-nitroso-1-phenylalkanes.

Paulsen-Sörman U, Lundkvist G, Khuthier AH, Lindeke B.

Chem Biol Interact. 1983 Oct 15;47(1):1-14.

PMID:
6640782
26.
27.

N- and alpha C-oxidation of alpha-alkyl substituted phenethylamines by a reconstituted cytochrome P-450 oxidase system from rabbit liver.

Duncan JD, Hallström G, Florence VM, Cho AK, Lindeke B.

Acta Pharm Suec. 1983;20(5):331-40. No abstract available.

PMID:
6421086
28.

Effects of alpha-carbon substituents on the N-demethylation of N-methyl-2-phenethylamines by rat liver microsomes.

Duncan JD, Hallström G, Paulsen-Sörman U, Lindeke B, Cho AK.

Drug Metab Dispos. 1983 Jan-Feb;11(1):15-20.

PMID:
6132789
30.

The opposing effects of N-hydroxyamphetamine and N-hydroxyphentermine on the H2O2 generated by hepatic cytochrome P-450.

Cho AK, Maynard MS, Matsumoto RM, Lindeke B, Paulsen U, Miwa GT.

Mol Pharmacol. 1982 Sep;22(2):465-70.

PMID:
7144739
31.

The non- and postenzymatic chemistry of N-oxygenated molecules.

Lindeke B.

Drug Metab Rev. 1982;13(1):71-121. Review. No abstract available.

PMID:
7044734
33.
34.
35.

Microsomal formation and chemical decomposition of pargyline N-oxide.

Hallström G, Lindeke B, Khuthier AH, Al-Iraqi MA.

Chem Biol Interact. 1981 Mar 1;34(2):185-200.

PMID:
7460082
36.

Cytochrome P-455 complex formation in the metabolism of phenylalkylamines-V. Complex formation in human liver microsomes from various sources.

Lindeke B, Paulsen U, von Bahr C, Groth CG.

Biochem Pharmacol. 1981 Feb 15;30(4):388-90. No abstract available.

PMID:
7213426
37.

Determination of oxybutynin (4-diethylaminobut-2-ynyl 2-cyclohexyl-2-phenylglycolate) in serum and urine by gas chromatography/mass spectrometry with single ion detection.

Lindeke B, Brötell H, Karlén B, Rietz G, Vietorisz A.

Acta Pharm Suec. 1981;18(1):25-34. No abstract available.

PMID:
7246190
38.

Synthesis and mass spectrometric investigations of metabolites of N-(5-pyrrolidino-pent-3-ynyl)succinimide (BL 14).

Hallström G, Anderson E, Lindeke B.

Acta Pharm Suec. 1980;17(1):31-54. No abstract available.

PMID:
7424535
39.
40.

Cytochrome P450 product complexes and glutathione consumption produced in isolated hepatocytes by norbenzphetamine and its N-oxidized congeners.

Hirata M, Lindeke B, Orrenius S.

Biochem Pharmacol. 1979;28(4):479-84. No abstract available.

PMID:
426867
41.

On the chemical stability of beta-hydroxyphenylalkylhydroxylamines and its relevance to the metabolism of amphetamines and ephedrines.

Lindeke B, Cho AK, Jonsson U, Paulsen U.

Life Sci. 1978 Sep 4;23(9):921-6. No abstract available.

PMID:
30016
42.
44.
46.

On the formation of cytochrome P-450 product complexes during the metabolism of phenylalkylamines.

Jonsson J, Lindeke B.

Acta Pharm Suec. 1976;13(4):313-20. No abstract available.

PMID:
998274
47.

Peptides related to melanostatin (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor.

Björkman S, Castensson S, Lindeke B, Sievertsson H.

Acta Pharm Suec. 1976;13(4):289-98. No abstract available.

PMID:
11638
48.

Oxidation of phenethylamine yielding tyramine by rat liver microsomes.

Jonsson J, Lindeke B, Cho AK.

Acta Pharmacol Toxicol (Copenh). 1975 Nov;37(5):352-60. No abstract available.

PMID:
1242862
49.

The p-hydroxylation of amphetamine and phentermine by rat liver microsomes.

Cho AK, Hodshon BJ, Lindeke B, Jonsson J.

Xenobiotica. 1975 Sep;5(9):531-8.

PMID:
242122
50.

Supplemental Content

Loading ...
Support Center